Targeted molecular therapy on the horizon for large b-cell lymphomas

RESEARCH DETAILS

Led by Dr. Ari Melnick from Weill Cornell Medical College in New York, researchers have identified a nontoxic small-molecule inhibitor that seems capable of killing human lymphoma cells.

Here's what we know: The oncogene known as BCL6 is generally associated with diffuse large B-cell lymphoma (DLBCL). In order for DLBCL cells to survive, they need BCL6. When this gene is prevented from functioning, DLBCL cells die.

So researchers have gone looking for the right BCL6 inhibitor, and they may have found it in a compound known as 79-6, which has proven effective in killing the DLBCL cell lines.

The discovery leads researchers to believe that such small compounds, and their ability to inhibit the growth of lymphoma cells, may provide a new therapeutic route for the successful treatment of lymphomas.

PUBLICATION & SOURCES

These findings were published in the journal Cancer Cell.

By Ross Bonander

Source: Medical News Today

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...